TGTX vs. ARIS
TGTX (TG Therapeutics, Inc.) and ARIS (Aris Water Solutions, Inc.) are both stocks. TGTX operates in Biotechnology (Healthcare), while ARIS operates in Utilities - Regulated Water (Utilities). Over the past 3 years, TGTX returned 21.69%/yr vs 88.30%/yr for ARIS. At a 0.11 correlation, their price movements are largely independent.
Performance
TGTX vs. ARIS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TGTX achieves a 66.12% return, which is significantly higher than ARIS's -2.09% return.
TGTX
- 1D
- 3.06%
- 1M
- 16.11%
- YTD
- 66.12%
- 6M
- 57.96%
- 1Y
- 32.51%
- 3Y*
- 21.69%
- 5Y*
- 5.57%
- 10Y*
- 21.61%
ARIS
- 1D
- 5.23%
- 1M
- -19.38%
- YTD
- -2.09%
- 6M
- 1.15%
- 1Y
- 135.76%
- 3Y*
- 88.30%
- 5Y*
- —
- 10Y*
- —
TGTX vs. ARIS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
TGTX TG Therapeutics, Inc. | 66.12% | -0.96% | 76.23% | 44.38% | -37.74% | -40.27% |
ARIS Aris Water Solutions, Inc. | -2.09% | 363.71% | 6.54% | 31.93% | -39.60% | 1.33% |
Correlation
The correlation between TGTX and ARIS is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Oct 22, 2021 | 0.11 |
Fundamentals
TGTX:
$7.93B
ARIS:
$3.32B
TGTX:
$2.87
ARIS:
$0.87
TGTX:
17.23
ARIS:
18.19
TGTX:
0.03
ARIS:
0.36
TGTX:
11.37
ARIS:
2.76
TGTX:
13.59
ARIS:
2.11
TGTX:
$700.35M
ARIS:
$1.14B
TGTX:
$581.54M
ARIS:
$612.94M
TGTX:
$156.88M
ARIS:
$432.53M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TGTX vs. ARIS — Risk / Return Rank
TGTX
ARIS
TGTX vs. ARIS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for TG Therapeutics, Inc. (TGTX) and Aris Water Solutions, Inc. (ARIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TGTX | ARIS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.17 | ||
| Sortino ratioReturn per unit of downside risk | -1.52 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.40 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | 1.00 | 4.87 | -3.87 |
| Martin ratioReturn relative to average drawdown | 1.81 | 16.85 | -15.04 |
Loading charts...
Drawdowns
TGTX vs. ARIS - Drawdown Comparison
The maximum TGTX drawdown since its inception was -99.52%, which is greater than ARIS's maximum drawdown of -57.98%. Use the drawdown chart below to compare losses from any high point for TGTX and ARIS.
Loading charts...
Drawdown Indicators
| TGTX | ARIS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.52% | -57.98% | -41.54% |
Max Drawdown (1Y)Largest decline over 1 year | -32.66% | -34.32% | +1.66% |
Max Drawdown (3Y)Largest decline over 3 years | -75.42% | -34.46% | -40.96% |
Max Drawdown (5Y)Largest decline over 5 years | -90.75% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -93.19% | — | — |
Current DrawdownCurrent decline from peak | -78.79% | -26.61% | -52.18% |
Average DrawdownAverage peak-to-trough decline | -91.43% | -22.67% | -68.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.04% | 9.35% | +8.69% |
Volatility
TGTX vs. ARIS - Volatility Comparison
The current volatility for TG Therapeutics, Inc. (TGTX) is 15.65%, while Aris Water Solutions, Inc. (ARIS) has a volatility of 21.05%. This indicates that TGTX experiences smaller price fluctuations and is considered to be less risky than ARIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TGTX | ARIS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.65% | 21.05% | -5.40% |
Volatility (6M)Calculated over the trailing 6-month period | 34.28% | 46.30% | -12.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.22% | 58.35% | -11.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 87.77% | 53.11% | +34.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.88% | 53.11% | +33.77% |
Dividends
TGTX vs. ARIS - Dividend Comparison
Neither TGTX nor ARIS has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
ARIS Aris Water Solutions, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 3.84% | 0.85% |
TGTX TG Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
TGTX vs. ARIS - Financials Comparison
This section allows you to compare key financial metrics between TG Therapeutics, Inc. and Aris Water Solutions, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TGTX vs. ARIS - Profitability Comparison
TGTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.
ARIS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aris Water Solutions, Inc. reported a gross profit of 217.03M and revenue of 372.48M. Therefore, the gross margin over that period was 58.3%.
TGTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.
ARIS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aris Water Solutions, Inc. reported an operating income of 179.05M and revenue of 372.48M, resulting in an operating margin of 48.1%.
TGTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.
ARIS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aris Water Solutions, Inc. reported a net income of 97.61M and revenue of 372.48M, resulting in a net margin of 26.2%.
Frequently Asked Questions
TGTX and ARIS have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARIS has higher volatility (21.05%) compared to TGTX (15.65%). In terms of maximum drawdown, TGTX dropped -99.52% vs ARIS's -57.98%.
ARIS currently has the higher Sharpe Ratio (2.87 vs 0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TGTX and ARIS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer